Finn
NGVT Specialty Chemicals · Small cap · Transformation · Auto supplier · Thesis updated November 8, 2026

High carbon margins offset pavement headwinds as portfolio cleanup stalls

01 Running thesis

The smaller company hits a speed bump

Ingevity is trying to become New Ingevity, a smaller and cleaner chemicals company built around two businesses: Performance Materials and Pavement Technologies. The bull case is that this plan makes the good parts easier to see. Performance Materials is highly profitable, hitting a 54.1 percent EBITDA margin in Q3 2026. The segment gets help from buyers choosing hybrid vehicles instead of battery electric vehicles, and commercial adoption in biogas purification and PFAS filtration provides a growth path that does not depend on cars.

The bear case remains focused on execution delays and raw material costs. Advanced Polymer Technologies, or APT, is still waiting to be sold. Management expects the announcement of a deal to extend into early 2027 as they try to secure a better valuation. A weak deal or no deal would keep the main execution risk alive.

Operating headwinds are also increasing. Higher asphalt prices have surged nearly 50 percent this year in some US regions. This inflation forces road contractors to spend their limited budgets on basic maintenance instead of new paving, introducing a severe near-term headwind for the Pavement Technologies segment.

Nov 2026▼Q3 2026 earnings revealed the APT sale is delayed to early 2027. Pavement Technologies faces severe headwinds from a 50 percent increase in US asphalt costs.
Jul 2026▲Q2 2026 earnings revealed a major PFAS filtration contract win, 10 million dollars in stranded cost reductions, and confirmation that the APT sale is in an advanced stage.
Jul 2026▲Management confirmed the successful closing of the Road Markings and Industrial Specialties divestitures, and repurchased 52 million dollars of shares.
May 2026→Q1 2026 confirmed the New Ingevity plan is moving forward. Performance Materials benefited from hybrid vehicle demand, but APT margin compression kept the update mixed.
May 2026▲The 10-Q confirmed two cleanup wins. Road markings was sold to PPG for 65 million dollars, and the BASF litigation was settled and paid for 113.2 million dollars.
Feb 2026▼The 2025 10-K shifted the story toward portfolio execution risk. Ingevity announced the New Ingevity plan, but also recorded large impairments tied to APT and road markings.
Nov 2025→The industrial specialties divestiture clarified the portfolio, while APT revenue pressure and Performance Chemicals margin pressure made the operating picture less clean.
Aug 2025▼APT weakened sharply, including a 183.8 million dollar goodwill impairment. That raised the risk that one troubled segment could offset progress elsewhere.
02 Business model

High-margin carbon, road additives, and exits

Ingevity makes money by selling specialty chemical products to industrial customers. Its most valuable business is Performance Materials, which sells hardwood-based activated carbon used in gasoline vapor control systems and filtration. This segment drives the bulk of company profits, supported by price increases and hybrid vehicle demand.

Pavement Technologies sells additives and tools used in asphalt construction, preservation, and recycling. This business depends on road budgets, contractor activity, and the price of asphalt itself. When crude oil inflation drives asphalt costs up, as seen in late 2026, customers cut back on expensive new paving projects.

The model can break if the simplification plan stalls. Road markings was sold to PPG for 65 million dollars, and industrial specialties for 93 million dollars. APT remains the bigger open item. If that sale fails to secure a favorable multiple, or if the remaining 10 million dollars of stranded costs stay in the business, the go-forward margin profile will look less clean than the bull case expects.

03 Product portfolio

What stays, what goes

Cash cow

Automotive activated carbon

This is the core Performance Materials product line. It helps control gasoline vapor emissions in internal combustion and hybrid vehicles, and it drives very high segment margins.

Growth engine

Filtration activated carbon

Ingevity sells activated carbon for food, water, and chemical filtration. Municipal contracts for PFAS water treatment and accelerating biogas projects validate this as a major growth vector.

Steady

Pavement Technologies

This product line sells asphalt additives and road technologies. It is a core part of New Ingevity, though highly sensitive to asphalt costs that currently restrict customer budgets.

Option

Advanced Polymer Technologies

APT makes caprolactone-based polymers used in end markets like automotive, footwear, and industrial products. The segment is awaiting a sale expected in early 2027.

04 Business segments

Mix before the next sale

Performance Materials60%modest
Performance Chemicals23%flat
Advanced Polymer Technologies17%modest

Segment shares use Q1 2026 net sales from continuing operations: Performance Materials 155.4 million dollars, Performance Chemicals 58.3 million dollars, and APT 44.3 million dollars. The mix will change when APT is sold.

05 Risk factors

What could still go wrong

APT sale delays or disappoints

High impact · Medium odds

APT is the largest remaining piece of the portfolio cleanup. The sale process has been delayed to early 2027. A complex deal structure or weak end markets could reduce the valuation, or leave Ingevity owning a weaker business longer than planned.

We watchA definitive APT sale agreement, sale price, and buyer terms by early 2027.

High asphalt prices crush pavement demand

Medium impact · High odds

Higher oil prices pushed US asphalt prices up nearly 50 percent in 2026. This severely slowed pavement opportunities as customers shifted finite budgets to road maintenance instead of new paving.

We watchUS asphalt prices, Pavement Technologies sales volume, and North American infrastructure spending trends.

EV shift cuts the carbon runway

High impact · Medium odds

Performance Materials depends on internal combustion and hybrid vehicles because its carbon products control gasoline vapors. The business currently benefits from a consumer shift toward hybrids, but a faster move to battery electric vehicles would shrink the need for this product.

We watchGlobal internal combustion and hybrid production, battery electric vehicle share, and PFAS contract revenue growth.

Stranded costs stay too high

Medium impact · Medium odds

Selling businesses does not remove every related cost on day one. Ingevity must eliminate 20 million dollars of indirect costs from recent sales. It removed 10 million dollars by mid-2026, but missing the rest would pressure New Ingevity margins.

We watchUpdates on the remaining 10 million dollars in indirect cost savings.
06 Quick answers

In one breath

What does Ingevity actually make?

Ingevity makes specialty chemical products. Its key products include activated carbon for gasoline vapor control and water filtration, asphalt additives for roads, and caprolactone-based polymers in APT.

Why is Ingevity selling businesses?

Management wants to create New Ingevity, a simpler company focused on higher-margin areas. It sold industrial specialties and road markings, and APT is awaiting a sale expected in early 2027.

Why do hybrid cars matter for NGVT?

Hybrids still use gasoline engines, so they need vapor control systems that use Ingevity activated carbon. That helps Performance Materials buy time while the company develops new markets like PFAS filtration.

What is the biggest near-term catalyst?

The biggest catalyst is a clear outcome for APT. A sale at a fair price would make the portfolio cleaner, while further delays would keep the main execution risk alive.

07 Research standards

Sources and research notes

This page combines Finn's company research with public filings and other cited materials. The thesis is reviewed when material company information changes; Finn Scores use the latest available scoring data.

Thesis reviewed
November 8, 2026
Score data
November 15, 2026
Reviewed by
Shivam Bharuka
  1. Ingevity Q3 2026 earnings call transcript
  2. Ingevity Q2 2026 earnings call transcript
  3. Ingevity Q1 2026 Form 10-Q
  4. Ingevity 2025 Form 10-K
08 Explore the industry

Comparable Specialty Chemicals companies

Companies near Ingevity Corporation in Finn's Specialty Chemicals industry ranking.

Get started with Finn today